
Leebras Pharmaceuticals Private Limited
About Leebras Pharmaceuticals Private Limited
Data last updated:
Leebras Pharmaceuticals Private Limited is a private limited company based in Gorakhpur, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 20 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24239UP2016PTC083364. Its GSTIN is 09AADCL0750C1ZX (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Babita Gaur and Amit Kumar Gaur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 497B Humayunpur North, Gorakhpur, Uttar Pradesh, India – 273015.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address497B Humayunpur North, Gorakhpur, Uttar Pradesh, India – 273015
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Leebras Pharmaceuticals Private Limited FY 2025 filings available
Leebras Pharmaceuticals Private Limited reported revenue of ₹749 for FY 2024.
Compounded Annual Growth Rate (CAGR) of Leebras Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 18% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Leebras Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Leebras Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Leebras Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Leebras Pharmaceuticals Private Limited
Leebras Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aoos Pharmaceuticals Private Limited | ₹1,000 (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Harshini Pharmaceuticals Private Limited | ₹1,000 (FY 2024) | •••• | •••• | •••• | Chennai, Tamil Nadu, India | |
| Care Core Pharmaceuticals Private Limited | ₹928 (FY 2024) | •••• | •••• | -98.0% | •••• | Bhopal, Madhya Pradesh, India |
| Reviresco Pharmaceuticals Private Limited | ₹858 (FY 2022) | •••• | •••• | 302.0% | •••• | Delhi, India |
| Disrac Pharmaceuticals Private Limited | ₹811 (FY 2021) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Leebras Pharmaceuticals Private Limited this company | ₹749 (FY 2024) | •••• | •••• | •••• | Gorakhpur, Uttar Pradesh, India | |
| Vaishnolight Pharmaceuticals Private Limited | ₹620 (FY 2024) | •••• | •••• | 5.0% | •••• | Uttar Pradesh, India |
| Arambh Pharmaceuticals Private Limited | ₹600 (FY 2018) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Sthyaga Pharmaceuticals Private Limited | ₹590 (FY 2022) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Dhanvir Pharmaceuticals Private Limited | ₹540 (FY 2025) | •••• | •••• | -99.0% | •••• | Chennai, Tamil Nadu, India |
| Sharent Pharmaceuticals Private Limited | ₹500 (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Leebras Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Leebras Pharmaceuticals Private Limited
Leebras Pharmaceuticals Private Limited is audited by FARHAN HUSSAIN for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| FARHAN HUSSAIN | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Leebras Pharmaceuticals Private Limited
Leebras Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Babita Gaur | Director | 20 May 2016 | 10 Years 4 Months | Current |
| Amit Kumar Gaur | Director | 20 May 2016 | 10 Years 4 Months | Current |
Ownership and Shareholding of Leebras Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Leebras Pharmaceuticals Private Limited
Leebras Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Leebras Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Leebras Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Leebras Pharmaceuticals Private Limited
Leebras Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Amit Kumar Gaur was appointed as Director on 20 May 2016.
Credit Ratings, Litigation & Regulatory Alerts for Leebras Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Leebras Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Leebras Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Leebras Pharmaceuticals Private Limited
Leebras Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AADCL0750C1ZX | Uttar Pradesh | Active | 01 Apr 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Leebras Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Leebras Pharmaceuticals Private Limited
Leebras Pharmaceuticals is an active private limited company based in Gorakhpur, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 20 May 2016 (10+ years old) and is registered under CIN U24239UP2016PTC083364.
Leebras Pharmaceuticals has 2 current directors:
- Babita Gaur - Director
- Amit Kumar Gaur - Director
The GSTIN of Leebras Pharmaceuticals is 09AADCL0750C1ZX, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Leebras Pharmaceuticals is U24239UP2016PTC083364. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Leebras Pharmaceuticals was incorporated on 20 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Leebras Pharmaceuticals by revenue are Aoos Pharmaceuticals Private Limited, Harshini Pharmaceuticals Private Limited, Care Core Pharmaceuticals Private Limited, Reviresco Pharmaceuticals Private Limited, Disrac Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Amit Kumar Gaur was appointed as Director on 20 May 2016. Babita Gaur was appointed as Director on 20 May 2016.
The registered office of Leebras Pharmaceuticals is at 497B Humayunpur North, Gorakhpur, Uttar Pradesh, India – 273015.
Leebras Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.
Leebras Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
No. Leebras Pharmaceuticals is not listed on any stock exchange. It is an unlisted company.